Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07736196
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07736196
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07736196. Randomized; no masking; primary purpose treatment. Start 2026-07-15 (anticipated); primary completion 2029-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI (percutaneous coronary intervention))
- Condition
- Dual Anti-platelet Therapy
- Intervention (Drug)
- Aspirin-Free Strategy
- Intervention (Drug)
- Dual Antiplatelet Therapy
- Lead sponsor
- Assiut University
Record details
- Record id
cardio:ct-nct07736196- Content hash
1311fddb13cb8c36d11c625e4c21a60348ca08343fdd50557db54d7fcfb1574e